skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

29 Total results for product and free and sample content found

Scrip

CVS/Aetna To Merge In Defensive Play To Reshape Healthcare Delivery

By Jessica Merrill 07 Dec 2017

The pharmacy retail chain and drug distributor will buy the insurer for $69bn in a merger to build a new healthcare concept.

Topic Reimbursement

Pink Sheet

OMB's Grogan Talks Drug Pricing And Taking On 'Sacred Cows'

By Cathy Kelly 16 Nov 2017

Concerns with promoting competition and reducing consumers' 'pain in the pocketbook' are key tenets of the Trump Administration's approach. 

Topic Reimbursement

Medtech Insight

New UK Pathway To Cut Access Times For Breakthrough Products By Up To Four Years

06 Nov 2017

The government’s much heralded response to the UK’s Accelerated Access Review backs proposals such as an accelerated pathway.

Topic Reimbursement

Medtech Insight

Digital Health In The EU: What Are The New Rules And Reimbursement Challenges?

By Amanda Maxwell 06 Nov 2017

Digital health products are struggling gain traction in the EU in part due to an undefined regulatory situation and lack of funding structures.

Topic Reimbursement

Pink Sheet

Drug Pricing Legislation Appears Nowhere In Sight Following Senate Hearing

By Michael Cipriano 18 Oct 2017

Senators and witnesses rehashed years-old arguments and found little common ground

Topic Reimbursement

Scrip

Shire Vs Allergan Brings Exclusive Contracts Out Of The Shadows

By Jessica Merrill 04 Oct 2017

Shire filed a lawsuit against Allergan, claiming that Allergan's exclusive contracting tactics for Restasis under Medicare Part D have blocked Xiidra from the market.

Topic Reimbursement

Scrip, In Vivo, Pink Sheet, Medtech Insight

What actually keeps biopharma execs up at night?

07 Sep 2017

What actually keeps biopharma execs up at night? Take our quiz to find out. 

Topic Deal trends Diseases Drug development landscape FDA Medtech Personalized Medicine Parkinsons disease Reimbursement

Pink Sheet

Novartis Begins CAR-T Payment Experiments With Outcomes-Based Contract With CMS

By Cathy Kelly 01 Sep 2017

The Centers for Medicare and Medicaid Services will only pay for Kymriah if patients respond after one month.

Topic Reimbursement

Pink Sheet

Biogen Ventures Into Value-Based Contracts In Multiple Sclerosis

By Cathy Kelly 10 Aug 2017

Four contracts test approaches tying reimbursement to relapse rates and discontinuation of treatment.

Topic Reimbursement

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: